Bionano Genomics Inc (NASDAQ: BNGO) is -86.46% lower on its value in year-to-date trading and has touched a low of $0.25 and a high of $2.27 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BNGO stock was last observed hovering at around $0.28 in the last trading session, with the day’s loss setting it -0.02%.
Currently trading at $0.26, the stock is -13.56% and -30.32% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.67 million and changing -7.58% at the moment leaves the stock -65.37% off its SMA200. BNGO registered -81.72% loss for a year compared to 6-month loss of -76.95%. The firm has a 50-day simple moving average (SMA 50) of $0.3708 and a 200-day simple moving average (SMA200) of $0.7434.
The stock witnessed a -23.20% gain in the last 1 month and extending the period to 3 months gives it a -52.20%, and is -13.14% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.18% over the week and 10.12% over the month.
Bionano Genomics Inc (BNGO) has around 344 employees, a market worth around $24.54M and $33.33M in sales. Profit margin for the company is -407.34%. Distance from 52-week low is 1.95% and -88.73% from its 52-week high. The company has generated returns on investments over the last 12 months (-250.76%).
The EPS is expected to grow by 82.71% this year
64.0 institutions hold shares in Bionano Genomics Inc (BNGO), with institutional investors hold 12.83% of the company’s shares. The shares outstanding are 95.88M, and float is at 95.27M with Short Float at 10.32%. Institutions hold 12.81% of the Float.
